Rabies human monoclonal antibody rdna

Sold as Rabies mab cipla

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Cipla Medpro (Pty) Ltd	Rabies mab cipla	100 IU	580161	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Rabies mab cipla EACH 1,0 ml SOLUTION CONTAINS: RABIES HUMAN MONOCLONAL ANTIBODY (rDNA) 40,0 IU	100 IUSolution for injection	58016158/30.1/0161Approved 7 July 2026	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsRabies mab cipla, Cipla Medpro (Pty) Ltd Patient information leaflet (PIL)For patients and carersRabies mab cipla, Cipla Medpro (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background